Skip to main content

Register Now for the Hepatitis C Educational Webinar

Last updated on

AbbVie, a contracted drug manufacturer for the Texas Health and Human Services Commission (HHSC), will host a webinar for prescribers called Treating Hepatitis C with Mavyret in Your Practice on March 6, 2024. AbbVie was contracted to improve awareness, screening, diagnosis, and treatment of the Hepatitis C Virus (HCV) for Medicaid clients. Prescribers can register now through Friday, March 1, 2024. Managed care organizations (MCOs) are encouraged to share information about this event with their provider networks.

Available Webinar Times

The following times are available for this webinar on Wednesday, March 6, 2024:

  • 12:15 p.m. Central Time
  • 11:15 a.m. Mountain Time

Register Online

Prescribers can register for the webinar on the AbbVie web page.

Note: HCV is a liver infection caused by a virus and often develops into a long-term or chronic illness. If untreated, HCV can cause significant damage to the body and may result in liver cancer or cirrhosis.

Email with comments or any questions.